Statista, a global data company that publishes insights for 170 industries, projects four cancer therapies will be among the top 10 best-selling pharmaceutical products in the U.S. this year. The ...
Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease. Published in Translational ...
Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...
A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...
Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know about peptides’ safety.
Voluntary MFN commitments by 16 manufacturers reportedly cover ~70% of Medicare drug spending, potentially obviating GUARD/GLOBE finalization while avoiding predictable legal challenges. Lindsay ...
Colorectal cancer is one of the cancers where, if found early, it has a 91% chance of survival for the patient. If you find ...
At least 111 substances of unknown safety have been added to foods, drinks and supplements sold in the United States without ...
But the FDA’s decision does not preclude CMS from determining that the higher dose is not reasonable and necessary — ...
The report shows that companies — not the FDA — determined the safety of these ingredients under a decades-old exemption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results